|
US6008202A
(en)
*
|
1995-01-23 |
1999-12-28 |
University Of Pittsburgh |
Stable lipid-comprising drug delivery complexes and methods for their production
|
|
US5795587A
(en)
*
|
1995-01-23 |
1998-08-18 |
University Of Pittsburgh |
Stable lipid-comprising drug delivery complexes and methods for their production
|
|
JP2001510457A
(ja)
*
|
1996-11-12 |
2001-07-31 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
インビボ送達に有効な、脂質―核酸複合体の安定な製剤の調製
|
|
US6210707B1
(en)
*
|
1996-11-12 |
2001-04-03 |
The Regents Of The University Of California |
Methods of forming protein-linked lipidic microparticles, and compositions thereof
|
|
EP0969876A2
(en)
*
|
1997-04-17 |
2000-01-12 |
Paola Leone |
Delivery system for gene therapy to the brain
|
|
US6749863B1
(en)
|
1997-11-19 |
2004-06-15 |
Georgetown University |
Targeted liposome gene delivery
|
|
WO2000003683A2
(en)
*
|
1998-07-20 |
2000-01-27 |
Inex Pharmaceuticals Corporation |
Liposomal encapsulated nucleic acid-complexes
|
|
ATE511543T1
(de)
*
|
1999-02-22 |
2011-06-15 |
Univ Georgetown |
Immunoliposome mit einem targeting- antikörperfragment zur systemischen genverabreichung
|
|
US9034329B2
(en)
*
|
1999-02-22 |
2015-05-19 |
Georgetown University |
Preparation of antibody or an antibody fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof
|
|
US7780882B2
(en)
|
1999-02-22 |
2010-08-24 |
Georgetown University |
Simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome for systemic administration of a therapeutic or diagnostic agent
|
|
PL351487A1
(en)
*
|
1999-03-02 |
2003-04-22 |
Liposome Co Inc |
Encapsulation of bioactive complexes in liposomes
|
|
EP1754488A1
(en)
*
|
1999-05-24 |
2007-02-21 |
Introgen Therapeutics, Inc. |
Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases
|
|
ATE340560T1
(de)
*
|
1999-05-24 |
2006-10-15 |
Introgen Therapeutics Inc |
Verfahren und zusammensetzungen für nichtvirale gentherapie zur behandlung von hyperproliferativen krankheiten
|
|
US7067111B1
(en)
|
1999-10-25 |
2006-06-27 |
Board Of Regents, University Of Texas System |
Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
|
|
US7189705B2
(en)
*
|
2000-04-20 |
2007-03-13 |
The University Of British Columbia |
Methods of enhancing SPLP-mediated transfection using endosomal membrane destabilizers
|
|
US10293056B1
(en)
*
|
2000-05-24 |
2019-05-21 |
Board Of Regents, The University Of Texas System |
Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases
|
|
ES2518926T3
(es)
|
2000-06-02 |
2014-11-05 |
Board Of Regents, The University Of Texas System |
Conjugados de etilendicisteína y un análogo de glucosa
|
|
WO2002024232A2
(en)
*
|
2000-09-25 |
2002-03-28 |
Board Of Regents, The University Of Texas System |
Pei: dna vector formulations for in vitro and in vivo gene delivery
|
|
US20020146829A1
(en)
*
|
2000-11-29 |
2002-10-10 |
Aventis Pharmaceuticals Products Inc. |
Neutral and anionic colloidal particles for gene delivery
|
|
DE60228842D1
(de)
*
|
2001-04-02 |
2008-10-23 |
Univ Georgetown |
Vereinfachtes und verbessertes verfahren zur herstellung eines antikörper- oder antikörperfragment-targeted immunoliposoms oder polyplex für die systemische verabreichung eines therapeutischen oder diagnostischen mittels
|
|
US20030003048A1
(en)
*
|
2001-04-26 |
2003-01-02 |
Chun Li |
Diagnostic imaging compositions, their methods of synthesis and use
|
|
JP2004535388A
(ja)
*
|
2001-04-30 |
2004-11-25 |
ターゲティッド ジェネティクス コーポレイション |
脂質含有薬物送達複合体およびそれらの生成方法
|
|
EP1389182A1
(en)
*
|
2001-05-15 |
2004-02-18 |
Transgene S.A. |
Complexes for transferring substances of interest into a cell
|
|
FR2829136B1
(fr)
*
|
2001-08-29 |
2006-11-17 |
Aventis Pharma Sa |
Derives lipidiques d'aminoglycosides
|
|
US20030049203A1
(en)
*
|
2001-08-31 |
2003-03-13 |
Elmaleh David R. |
Targeted nucleic acid constructs and uses related thereto
|
|
US7261875B2
(en)
*
|
2001-12-21 |
2007-08-28 |
Board Of Regents, The University Of Texas System |
Dendritic poly (amino acid) carriers and methods of use
|
|
KR100466254B1
(ko)
*
|
2002-02-25 |
2005-01-14 |
한국과학기술원 |
세포내 전달을 위한 올리고뉴클레오티드와 친수성 고분자로 구성되는 유전자 전달용 접합체, 고분자 전해질 복합 미셀 및 그의 제조방법
|
|
WO2003097805A2
(en)
|
2002-05-15 |
2003-11-27 |
California Pacific Medical Center |
Delivery of nucleic acid-like compounds
|
|
US20040137064A1
(en)
*
|
2003-01-15 |
2004-07-15 |
Lewis David L. |
Compositions and processes using siRNA, amphipathic compounds and polycations
|
|
JP2005529959A
(ja)
*
|
2002-06-14 |
2005-10-06 |
マイラス コーポレイション |
細胞へのポリヌクレオチドの伝達をするための新規な方法
|
|
KR101086690B1
(ko)
*
|
2002-11-07 |
2011-11-25 |
셀>포인트, 엘엘씨 |
에틸렌디시스테인（ｅｃ）－약물 콘쥬게이트, 조성물 및조직 특이적 질환 영상 방법
|
|
ATE521701T1
(de)
|
2003-01-22 |
2011-09-15 |
Univ Duke |
Verbesserte konstrukte zur expression lysosomaler polypeptide
|
|
US7678540B2
(en)
*
|
2003-10-16 |
2010-03-16 |
University Of Massachusetts |
Template-directed assembly of receptor signaling complexes
|
|
US9050378B2
(en)
*
|
2003-12-10 |
2015-06-09 |
Board Of Regents, The University Of Texas System |
N2S2 chelate-targeting ligand conjugates
|
|
US20050261221A1
(en)
*
|
2004-03-01 |
2005-11-24 |
Li Wang |
Compositions and methods for enhanced delivery of compounds via transfection complexes
|
|
JP2007532573A
(ja)
*
|
2004-04-09 |
2007-11-15 |
バイオデリバリー サイエンシーズ インターナショナル インコーポレイティッド |
ヌクレオチド−渦巻状組成物および使用の方法
|
|
WO2006074108A2
(en)
*
|
2004-12-30 |
2006-07-13 |
Hauser Todd M |
Compositions and methods for modulating gene expression using self-protected oligonucleotides
|
|
AU2005326371A1
(en)
*
|
2005-01-28 |
2006-08-03 |
Kyowa Hakko Kirin Co., Ltd. |
Composition for inhibiting expression of target gene
|
|
WO2007080902A1
(ja)
*
|
2006-01-11 |
2007-07-19 |
Kyowa Hakko Kogyo Co., Ltd. |
眼球において標的遺伝子の発現を抑制する組成物および眼球における疾患の治療剤
|
|
US8906390B2
(en)
*
|
2006-03-24 |
2014-12-09 |
Gencia Corporation |
Synthetic lipid rafts and methods of use
|
|
US8758723B2
(en)
|
2006-04-19 |
2014-06-24 |
The Board Of Regents Of The University Of Texas System |
Compositions and methods for cellular imaging and therapy
|
|
WO2007127803A2
(en)
*
|
2006-04-25 |
2007-11-08 |
The Regents Of The University Of California |
Administration of growth factors for the treatment of cns disorders
|
|
US20070259031A1
(en)
*
|
2006-04-26 |
2007-11-08 |
The Regents Of The University Of California |
Compositions and methods for convection enhanced delivery of high molecular weight neurotherapeutics
|
|
MX2008014362A
(es)
*
|
2006-05-15 |
2008-11-27 |
Univ Georgetown |
Preparacion de inmunoliposomas dirigidos a anticuerpos o a fragmentos de anticuerpos para la administracion sistemica de agentes terapeuticos o de diagnostico y usos de los mismos.
|
|
US8541190B2
(en)
*
|
2006-06-28 |
2013-09-24 |
Robert M. Weis |
Methods and materials for in vitro analysis and/or use of membrane-associated proteins, portions thereof or variants thereof
|
|
US20080213349A1
(en)
*
|
2006-09-11 |
2008-09-04 |
Deepak Ramesh Thakker |
Liposome Complexes Containing Pharmaceutical Agents and Methods
|
|
US20100035974A1
(en)
*
|
2006-10-04 |
2010-02-11 |
Centre National De La Recherche Scientifique (Cnrs |
Compositions comprising a sirna and lipidic 4,5-disubstituted 2-deoxystreptamine ring aminoglycoside derivatives and uses thereof
|
|
US10925977B2
(en)
*
|
2006-10-05 |
2021-02-23 |
Ceil>Point, LLC |
Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
|
|
CN101678082B
(zh)
|
2007-03-26 |
2013-06-19 |
再生医药有限公司 |
使用cxcl9和抗cxcl9抗体促进骨髓保护和再生的方法
|
|
WO2009009054A1
(en)
*
|
2007-07-09 |
2009-01-15 |
Georgetown University |
Methods for generating immune response using cationic-liposome-mediated nucleic acid delivery
|
|
KR20110031168A
(ko)
*
|
2008-06-19 |
2011-03-24 |
니뽄 신야쿠 가부시키가이샤 |
약물 담체
|
|
CA2748520C
(en)
*
|
2008-12-26 |
2013-12-17 |
Se-Ho Kim |
Pharmaceutical composition containing an anionic drug, and a production method therefor
|
|
US9459247B2
(en)
|
2010-03-29 |
2016-10-04 |
Academia Sinica |
Quantitative measurement of nano/micro particle endocytosis with cell mass spectrometry
|
|
RU2436583C1
(ru)
*
|
2010-07-06 |
2011-12-20 |
Общество с ограниченной ответственностью "ВИТАЛАНГ" |
Противовирусное средство
|
|
JP5760562B2
(ja)
*
|
2011-03-22 |
2015-08-12 |
セイコーエプソン株式会社 |
読取装置および読取方法
|
|
AU2012312520A1
(en)
|
2011-09-20 |
2014-05-08 |
The University Of North Carolina At Chapel Hill |
Regulation of sodium channels by PLUNC proteins
|
|
US9238865B2
(en)
*
|
2012-02-06 |
2016-01-19 |
Asm Ip Holding B.V. |
Multiple vapor sources for vapor deposition
|
|
WO2016045732A1
(en)
|
2014-09-25 |
2016-03-31 |
Biontech Rna Pharmaceuticals Gmbh |
Stable formulations of lipids and liposomes
|
|
EP3405576A4
(en)
|
2016-01-19 |
2019-09-18 |
The University of North Carolina at Chapel Hill |
METHOD AND COMPOSITIONS WITH RNA INTERFERENCE FOR KRAS INHIBITION
|
|
AU2017222450A1
(en)
|
2016-02-22 |
2018-09-27 |
The University Of North Carolina At Chapel Hill |
Peptide inhibitors of calcium channels
|
|
US11788190B2
(en)
|
2019-07-05 |
2023-10-17 |
Asm Ip Holding B.V. |
Liquid vaporizer
|
|
EP4578503A3
(en)
*
|
2019-07-10 |
2025-09-03 |
University of Washington |
Non-viral immuno-targeting
|
|
US11946136B2
(en)
|
2019-09-20 |
2024-04-02 |
Asm Ip Holding B.V. |
Semiconductor processing device
|
|
GB202004254D0
(en)
|
2020-03-24 |
2020-05-06 |
Puridify Ltd |
Characterization of gene therapy vectors
|
|
WO2023054243A1
(ja)
*
|
2021-09-30 |
2023-04-06 |
日油株式会社 |
細胞指向性を有する脂質ナノ粒子
|
|
DE102023001946A1
(de)
*
|
2023-05-12 |
2024-11-14 |
Friedrich-Schiller-Universität Jena, Körperschaft des öffentlichen Rechts |
Nanopartikel für den Transport von Wirkstoffen mit anionischen Gruppen, Verfahren zu deren Herstellung und deren Verwendung
|
|
CN119490670A
(zh)
*
|
2024-11-26 |
2025-02-21 |
山东大学 |
一种慢病毒转染增强纳米颗粒及其制备方法与应用
|